Medicamen Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 325.2 million compared to INR 307.72 million a year ago. Revenue was INR 329.97 million compared to INR 309.04 million a year ago. Net income was INR 42.22 million compared to INR 32.24 million a year ago. Basic earnings per share from continuing operations was INR 3.46 compared to INR 2.64 a year ago. Diluted earnings per share from continuing operations was INR 3.46 compared to INR 2.64 a year ago. For the six months, sales was INR 600.51 million compared to INR 585.55 million a year ago. Revenue was INR 606.06 million compared to INR 587.71 million a year ago. Net income was INR 83.73 million compared to INR 54.68 million a year ago. Basic earnings per share from continuing operations was INR 6.85 compared to INR 4.48 a year ago. Diluted earnings per share from continuing operations was INR 6.85 compared to INR 4.48 a year ago.